Bausch Health Companies Inc. (BHC) financial statements (2021 and earlier)

Company profile

Business Address 2150 ST. ELZEAR BLVD. WEST
QUEBEC, QC H7L 4A8
State of Incorp. NJ
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6059778969123,243825878
Cash and cash equivalents6059778969123,243825878
Restricted cash and investments1,2111,0111,0111,011122
Receivables1,5771,7331,3691,7121,8391,7471,829
Inventory, net of allowances, customer advances and progress billings1,0941,2241,2261,1241,1071,1001,060
Inventory1,0941,2241,2261,1241,1071,1001,060
Other undisclosed current assets855726776745779631698
Total current assets:5,3425,6715,2785,5046,9694,3054,467
Noncurrent Assets
Property, plant and equipment1,5671,5501,4961,4501,4661,3901,372
Intangible assets, net (including goodwill)21,48922,08322,38122,76023,32723,70224,356
Goodwill13,04413,16013,08413,03413,12613,05213,160
Intangible assets, net (excluding goodwill)8,4458,9239,2979,72610,20110,65011,196
Deferred income tax assets2,1371,9131,8741,7401,6901,8681,799
Other noncurrent assets664345367411411402360
Total noncurrent assets:25,85725,89126,11826,36126,89427,36227,887
TOTAL ASSETS:31,19931,56231,39631,86533,86331,66732,354
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,9134,7324,7174,8825,0143,6353,649
Accounts payable337379447444503437527
Accrued liabilities4,5764,3534,2704,4384,5113,1983,122
Debt  141,23410056
Total current liabilities:4,9134,7324,7184,8866,2483,7353,705
Noncurrent Liabilities
Long-term debt and lease obligation23,92524,34324,35724,42424,66123,46624,023
Long-term debt, excluding current maturities23,92524,34324,35724,42424,66123,46624,023
Liabilities, other than long-term debt1,5401,8321,7751,7651,5561,6391,667
Deferred income tax liabilities528650694690705879884
Other liabilities1,012907802807851760783
Business combination, contingent consideration, liability 275279268   
Other undisclosed noncurrent liabilities216   262267271
Total noncurrent liabilities:25,68126,17526,13226,18926,47925,37225,961
Total liabilities:30,59430,90730,85031,07532,72729,10729,666
Stockholders' equity
Stockholders' equity attributable to parent5355874747191,0632,4822,601
Common stock10,22710,21910,21710,20910,17210,16810,165
Additional paid in capital454435411396429406384
Accumulated other comprehensive loss(2,133)(2,207)(2,223)(2,281)(2,086)(2,156)(2,061)
Accumulated deficit(8,013)(7,860)(7,931)(7,605)(7,452)(5,936)(5,887)
Stockholders' equity attributable to noncontrolling interest70687271737887
Total stockholders' equity:6056555467901,1362,5602,688
TOTAL LIABILITIES AND EQUITY:31,19931,56231,39631,86533,86331,66732,354

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues2,2132,1381,6642,0122,2242,2092,152
Cost of revenue(1,357)(999)(1,049)(991)(2,489)(1,072)(1,110)
Gross profit:8561,1396151,021(265)1,1371,042
Operating expenses(861)(679)(642)(773)(811)(808)(785)
Other operating expense, net(308)(16)(107)(23)(1,399)(10)(8)
Other undisclosed operating income30816107231,399108
Operating income (loss):(5)460(27)248(1,076)329257
Nonoperating income (expense)(2)(11)2(6)(1)116
Investment income, nonoperating2227323
Foreign currency transaction gain (loss), before tax(4)(13) (13)(4)93
Interest and debt expense(379)(374)(385)(396)(391)(406)(409)
Other undisclosed loss from continuing operations before equity method investments, income taxes(8) (27)(24)(2) (33)
Income (loss) from continuing operations before income taxes:(394)75(437)(178)(1,470)(66)(179)
Income tax expense (benefit)242(5)11226(47)189
Net income (loss):(152)70(325)(152)(1,517)(48)(170)
Net income (loss) attributable to noncontrolling interest 1(1) 1(1)(1)
Other undisclosed net loss attributable to parent(1)      
Net income (loss) available to common stockholders, diluted:(153)71(326)(152)(1,516)(49)(171)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):(152)70(325)(152)(1,517)(48)(170)
Other comprehensive income (loss)751958(197)71(97)55
Comprehensive income (loss):(77)89(267)(349)(1,446)(145)(115)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(2)(2)(1)2 1(1)
Comprehensive income (loss), net of tax, attributable to parent:(79)87(268)(347)(1,446)(144)(116)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: